Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol

about

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Role of CYP3A in Oral Contraceptives Clearance.

P2860

Q38681635-36EB9DBC-C36B-405C-A56C-E2EA2B510AF5 Q49544121-9EFCCBB7-249F-4349-AA8C-CC43223A6B0C

P2860

Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol

Item

http://www.wikidata.org/entity/Q36410060

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@ast

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@en

type

Item

label

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@ast

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@en

prefLabel

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@ast

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@en

P1476

Pharmacokinetic interaction be ...... ethinylestradiol or estradiol

@en

P2093

Barbara Schütt

http://www.w3.org/2001/XMLSchema#string

Frank S Zollmann

http://www.w3.org/2001/XMLSchema#string

Joachim Höchel

http://www.w3.org/2001/XMLSchema#string

Matthias Berse

http://www.w3.org/2001/XMLSchema#string

Simone Gschwend

http://www.w3.org/2001/XMLSchema#string

Stefan Klein

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.

General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies.

Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.

Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.

Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.

Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.

Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.

Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study.

P304

1399-1410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12745

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Herbert Wiesinger

P577

2015-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26271371

http://www.w3.org/2001/XMLSchema#string

P932

4693482

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol

about

P2860

P2860

Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932